Targeting FAK Radiosensitizes 3-Dimensional Grown Human HNSCC Cells Through Reduced Akt1 and MEK1/2 Signaling

This publication has 19 references indexed in Scilit:

• β1 Integrin/FAK/cortactin signaling is essential for human head and neck cancer resistance to radiotherapy
  Journal of Clinical Investigation, 2012
• Vandetanib Restores Head and Neck Squamous Cell Carcinoma Cells' Sensitivity to Cisplatin and Radiation In Vivo and In Vitro
  Clinical Cancer Research, 2011
• Suppression of uPAR Retards Radiation-Induced Invasion and Migration Mediated by Integrin β1/FAK Signaling in Medulloblastoma
  PLOS ONE, 2010
• Integrating Epidermal Growth Factor Receptor Assay With Clinical Parameters Improves Risk Classification for Relapse and Survival in Head-and-Neck Squamous Cell Carcinoma
  International Journal of Radiation Oncology - Biology - Physics (IJROBP), 2010
• PINCH1 regulates Akt1 activation and enhances radioresistance by inhibiting PP1α
  Journal of Clinical Investigation, 2010
• Radiation Response in Two HPV-Infected Head-and-Neck Cancer Cell Lines in Comparison to a Non–HPV-Infected Cell Line and Relationship to Signaling Through AKT
  International Journal of Radiation Oncology - Biology - Physics (IJROBP), 2009
• In vitro and In vivo Radiosensitization with AZD6244 (ARRY-142886), an Inhibitor of Mitogen-activated Protein Kinase/Extracellular Signal-regulated Kinase 1/2 Kinase
  Clinical Cancer Research, 2009
• Strategic Plans to Promote Head and Neck Cancer Translational Research Within the Radiation Therapy Oncology Group: A Report From the Translational Research Program
  International Journal of Radiation Oncology - Biology - Physics (IJROBP), 2007
• EGFR-targeted anti-cancer drugs in radiotherapy: Preclinical evaluation of mechanisms
  Radiotherapy and Oncology, 2007
• Human pancreatic tumor cells are sensitized to ionizing radiation by knockdown of caveolin-1
  Oncogene, 2007